News

A new antifungal molecule, devised by tweaking the structure of prominent antifungal drug Amphotericin B, has the potential to harness the drug’s power against fungal infections while doing away with its toxicity.

A team of researchers developed a method that measures water loss from the skin to predict anaphylaxis during oral food challenges before it becomes clinically evident.

Inflammatory bowel diseases start a long time before symptoms occur, with changes being detected in blood up to eight years before diagnosis.

A common, cat-borne parasite already associated with risk-taking behavior and mental illness in humans may also contribute to exhaustion, loss of muscle mass, and other signs of “frailty” in older adults,

In a recent study, researchers from Japan reveal that the bacterium Fusobacterium nucleatum may play a protective role in patients with non-eosinophilic CRS, enhancing our understanding of the mechanisms underlying allergic diseases.

Studying the evolutionary history of influenza viruses to quantitatively analyze how they evolved may help predict future strains and guide vaccine development.

Johns Hopkins researchers found that high levels of THC in adolescent mice caused brain immune cell changes linked to increased risk of psychiatric disorders and learning problems.

A new study published in Science Immunology has hinted at the possible molecular mechanisms linking exercise to inflammation control.

Using a technique that has shown promise in targeting cancer tumors, a Duke Health team has found a way to deploy a molecular warhead that can annihilate the bacterium that causes Lyme disease.

A novel treatment based on CAR-T cells could help tackle encephalitis, a common autoimmune disease, by targeting and eliminating disease-causing cells.